Consecuencias económicas

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre una nueva ventana)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Fuente‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indexado en‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (abre una nueva ventana)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (abre una nueva ventana)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Fuente‎: Transfusion 2017;57(6):1347-58.

Indexado en‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (abre una nueva ventana)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (abre una nueva ventana)

MacLaren R, Sullivan PW.

Fuente‎: Value Health 2005;8(2):105-16.

Indexado en‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (abre una nueva ventana)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre una nueva ventana)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Fuente‎: Transfusion 2015;55(12):2807-15.

Indexado en‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (abre una nueva ventana)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (abre una nueva ventana)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Fuente‎: Crit Care 2015;19:83.

Indexado en‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (abre una nueva ventana)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (abre una nueva ventana)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Fuente‎: Health Technol Assess 2013;17(10):1-79.

Indexado en‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (abre una nueva ventana)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (abre una nueva ventana)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Fuente‎: J Trauma 2009;66(1):63-72.

Indexado en‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (abre una nueva ventana)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (abre una nueva ventana)

Zilberberg MD, Shorr AF.

Fuente‎: BMC Health Serv Res 2007;7:138.

Indexado en‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (abre una nueva ventana)

CUIDADOS INTENSIVOS

Consecuencias económicas

español

Consecuencias económicas

https://assetsnffrgf-a.akamaihd.net/assets/ct/e781f8601f/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre una nueva ventana)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (abre una nueva ventana)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (abre una nueva ventana)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre una nueva ventana)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (abre una nueva ventana)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (abre una nueva ventana)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (abre una nueva ventana)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (abre una nueva ventana)

Contacte con un representante local del Comité de Enlace con los Hospitales

Archivos de información médica

Videos

Consecuencias económicas

Seleccione un idioma

Compartir